{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:57:45Z","timestamp":1772524665974,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41433-025-04196-0","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T02:19:15Z","timestamp":1767579555000},"page":"505-511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hydrus microstent versus triple iStent inject W combined with phacoemulsification for glaucoma management: three-year outcomes"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9359-1473","authenticated-orcid":false,"given":"Graham A.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenouda","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"4196_CR1","first-page":"4641","volume":"65","author":"RH Jayaram","year":"2024","unstructured":"Jayaram RH, Maheshwari A, Sarrafpour S, Liu J, Teng C. Trends for glaucoma surgeries in the United States from 2011 and 2021\u2013a national study. Invest Ophthal Vis Sci. 2024;65:4641.","journal-title":"Invest Ophthal Vis Sci"},{"key":"4196_CR2","unstructured":"GlobalData. Glaucoma surgery devices market size by segments, share, regulatory, reimbursement, interventions and forecast to 2036. London, UK: GlobalData; 2024. https:\/\/www.globaldata.com\/store\/report\/glaucoma-surgery-devices-market-analysis\/."},{"key":"4196_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/IJG.0000000000002249","volume":"32","author":"S Sood","year":"2023","unstructured":"Sood S, Iskander M, Heilenbach N, Chen D, Al-Aswad LA. A review of cost-effectiveness analyses for open angle glaucoma management. J Glaucoma. 2023;32:619\u201330.","journal-title":"J Glaucoma"},{"key":"4196_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s40123-025-01126-x","volume":"14","author":"IIK Ahmed","year":"2025","unstructured":"Ahmed IIK, Berdahl JP, Yadgarov A, Reiss GR, Sarkisian SR Jr, Gagn\u00e9, et al. Six-month outcomes from a prospective, randomized study of iStent infinite versus Hydrus in open-angle glaucoma: the INTEGRITY study. Ophthalmol Ther. 2025;14:1005\u201324.","journal-title":"Ophthalmol Ther"},{"key":"4196_CR5","doi-asserted-by":"publisher","first-page":"e051496","DOI":"10.1136\/bmjopen-2021-051496","volume":"12","author":"R Hu","year":"2022","unstructured":"Hu R, Guo D, Hong N, Xuan X, Wang X. Comparison of Hydrus and iStent microinvasive glaucoma surgery implants in combination with phacoemulsification for treatment of open-angle glaucoma: systematic review and network meta-analysis. BMJ Open. 2022;12:e051496.","journal-title":"BMJ Open"},{"key":"4196_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41433-019-0459-2","volume":"34","author":"GA Lee","year":"2020","unstructured":"Lee GA, Porter AJ, Vincent RA, Makk J, Vincent SJ. Combined phacoemulsification and microinvasive glaucoma surgery in comparison to phacoemulsification alone for open angle glaucoma. Eye. 2020;34:312\u20138.","journal-title":"Eye"},{"key":"4196_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/ceo.14048","volume":"50","author":"DP Holmes","year":"2022","unstructured":"Holmes DP, Clement CI, Nguyen V, Healey PR, Lim R, White A, et al. Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery. Clin Exp Ophthalmol. 2022;50:303\u201311.","journal-title":"Clin Exp Ophthalmol"},{"key":"4196_CR8","doi-asserted-by":"publisher","first-page":"e001946","DOI":"10.1136\/bmjophth-2024-001946","volume":"10","author":"K Komzak","year":"2025","unstructured":"Komzak K, Allen PL, Toh T. Minimally invasive glaucoma surgery: comparison of Hydrus microstent with iStent inject in primary open-angle glaucoma. BMJ Open Ophthalmol. 2025;10:e001946.","journal-title":"BMJ Open Ophthalmol"},{"key":"4196_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/IJG.0000000000002141","volume":"32","author":"JrSR Sarkisian","year":"2023","unstructured":"Sarkisian JrSR, Grover DS, Gallardo MJ, Brubaker JW, Giamporcaro JE, Hornbeak DM, et al. iStent infinite Study Group. Effectiveness and safety of iStent infinite trabecular micro-bypass for uncontrolled glaucoma. J Glaucoma. 2023;32:9\u201318.","journal-title":"J Glaucoma"},{"key":"4196_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ophtha.2024.07.030","volume":"132","author":"SJ Gedde","year":"2025","unstructured":"Gedde SJ, Vinod K, Bowden EC, Kolomeyer NN, Chopra V, Challa P, et al. Special commentary: reporting clinical endpoints in studies of minimally invasive glaucoma surgery. Ophthalmology. 2025;132:141\u201353.","journal-title":"Ophthalmology"},{"key":"4196_CR11","first-page":"2313","volume":"9","author":"LJ Katz","year":"2015","unstructured":"Katz LJ, Erb C, Carceller GA, Fea AM, Voskanyan L, Wells JM, et al. Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication. Clin Ophthalmol. 2015;9:2313\u201320.","journal-title":"Clin Ophthalmol"},{"key":"4196_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100389","volume":"4","author":"S Yousefi","year":"2023","unstructured":"Yousefi S, Huang X, Poursoroush A, Majoor J, Lemij H, Vermeer K, et al. An artificial intelligence enabled system for retinal nerve fiber layer thickness damage severity staging. Ophthalmol Sci. 2023;4:100389.","journal-title":"Ophthalmol Sci"},{"key":"4196_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/IJG.0000000000002318","volume":"33","author":"CA Strohmaier","year":"2024","unstructured":"Strohmaier CA, Wanderer D, Zhang X, Zhang HF, Strohmaier S, Weinreb RN, et al. Lack of correlation between segmental trabecular meshwork pigmentation and angiographically determined outflow in ex vivo human eyes. J Glaucoma. 2024;33:355\u201360.","journal-title":"J Glaucoma"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04196-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04196-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04196-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:13:20Z","timestamp":1772522000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04196-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4196"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04196-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7336280\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare there is no conflict of interest. Glaukos supplied the second iStent W device for the purposes of the study. Alice Chu PhD, MPH, MBA (Sr. Director, Market Access and Medical Affairs, Asia Pacific, Glaukos), provided statistical analysis with no role in interpretation of data or writing of the manuscript from Glaukos.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}